Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 16;12(2):e00006-21.
doi: 10.1128/mBio.00006-21.

One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway

Affiliations

One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway

Fabrice Jean-Pierre et al. mBio. .

Abstract

Culture-independent studies have revealed that chronic lung infections in persons with cystic fibrosis (pwCF) are rarely limited to one microbial species. Interactions among bacterial members of these polymicrobial communities in the airways of pwCF have been reported to modulate clinically relevant phenotypes. Furthermore, it is clear that a single polymicrobial community in the context of CF airway infections cannot explain the diversity of clinical outcomes. While large 16S rRNA gene-based studies have allowed us to gain insight into the microbial composition and predicted functional capacities of communities found in the CF lung, here we argue that in silico approaches can help build clinically relevant in vitro models of polymicrobial communities that can in turn be used to experimentally test and validate computationally generated hypotheses. Furthermore, we posit that combining computational and experimental approaches will enhance our understanding of mechanisms that drive microbial community function and identify new therapeutics to target polymicrobial infections.

Keywords: antibiotics; biofilms; chronic infection; cystic fibrosis; metabolic modeling; microbial communities; microbiome.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Characterization of the polymicrobial communities of sputum samples from cystic fibrosis inpatients and outpatients. (A) Fraction of 454 pyrosequencing reads assigned to each of the top 10 genera detected in the sample set as a whole is shown for sputum samples analyzed from inpatients (INPT; n = 13) and outpatients (OUTPT; n = 22) from a cross-sectional study. The legend on the right indicates the color assigned to each indicated genus. (B) Heat map of samples from pwCF based on Pearson hierarchical clustering of relative bacterial abundance using the data in panel A for the most prevalent four genera, which account for ∼86% of the total pyrosequencing reads. The legend at the bottom indicates the four clusters or “groups” assigned by hierarchical clustering, as reported (20). The airway infection communities from pwCF can be described by one of three profiles: (i) high Pseudomonas (group 1), (ii) high Streptococcus (group 3), and (iii) mixed communities with a relatively even distribution of taxa (groups 2 and 4). Modified from reference .
FIG 2
FIG 2
Predicted metabolite cross-feeding relationships between the four most abundant genera. One thousand model simulations were performed and split into 500 cases with relatively high Pseudomonas abundances and 500 cases with relatively low Pseudomonas abundances. The arrow thickness represents the magnitude of the metabolic exchange rate between the microbial species of the consortia. The color of the arrows is defined by the species producing and cross-feeding the metabolite(s) as follows: black arrow, Staphylococcus; red arrow, Streptococcus; blue arrow, Pseudomonas; green arrow, Prevotella. (A) Schematic representation of predicted metabolite exchange for Pseudomonas-dominated communities. (B) Schematic representation of predicted metabolite exchange for Streptococcus-dominated communities. Modified from reference .

Similar articles

Cited by

References

    1. Boucher RC. 2004. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23:146–158. doi:10.1183/09031936.03.00057003. - DOI - PubMed
    1. Surette MG. 2014. The cystic fibrosis lung microbiome. Ann Am Thorac Soc 11(Suppl 1):S61–S65. doi:10.1513/AnnalsATS.201306-159MG. - DOI - PubMed
    1. Armbruster CR, Coenye T, Touqui L, Bomberger JM. 2020. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis. J Cystic Fibrosis 19:S47–S53. doi:10.1016/j.jcf.2019.10.015. - DOI - PMC - PubMed
    1. Crabbé A, Jensen PO, Bjarnsholt T, Coenye T. 2019. Antimicrobial tolerance and metabolic adaptations in microbial biofilms. Trends Microbiol 27:850–863. doi:10.1016/j.tim.2019.05.003. - DOI - PubMed
    1. Ibberson CB, Whiteley M. 2020. The social life of microbes in chronic infection. Curr Opin Microbiol 53:44–50. doi:10.1016/j.mib.2020.02.003. - DOI - PMC - PubMed

Publication types

Substances